Synapticure Expands Rare Disease Telehealth Offering and Deepens Neurology Specialist Ties

Synapticure – a neurology-focused virtual care provider – featured prominently this week for expanding its telehealth platform and deepening engagement with specialist communities. The company launched a new nationwide service line for ataxia, a rare movement disorder, and highlighted its active presence at the American Academy of Neurology Annual Meeting.

The new ataxia offering is positioned as genetics-informed, comprehensive virtual care available across all 50 U.S. states, targeting an underserved rare disease population. Synapticure introduced the service following outreach at the National Ataxia Foundation’s Annual Ataxia Conference, where it engaged directly with patients, caregivers, and advocates.

By adding ataxia to its portfolio, Synapticure is extending its neurology platform beyond existing focus areas such as ALS, Parkinson’s disease, and Alzheimer’s. The move is framed as an effort to broaden its addressable market in rare neurological diseases, deepen patient and payer relationships, and build a scalable model that could be replicated across additional rare disease verticals.

At the American Academy of Neurology Annual Meeting, Synapticure underscored its role in neurology and brain health through thought leadership and networking. VP of Clinical Operations Melissa Yu, M.D., moderated a brain health panel, while the company hosted a branded happy hour and other networking events with clinicians and peers.

These conference activities emphasized improving patient access to neurological specialists, aligning with Synapticure’s virtual and technology-enabled care model. The company’s messaging pointed to efforts to address specialist shortages, streamline referral pathways, and strengthen clinical networks that may support future patient volume.

While no quantitative performance metrics or specific commercial agreements were disclosed, the combination of product expansion into ataxia and heightened visibility at major neurology forums signals continued strategic execution. Overall, the week’s developments reinforce Synapticure’s positioning as an emerging player in digital neurology and rare disease care, with a growing emphasis on nationwide access and specialist engagement.